Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Pathobiont-Induced Suppressive Immune Imprints Thwart T Cell Vaccine Responses

Pathobiont-Induced Suppressive Immune Imprints Thwart T Cell Vaccine Responses

Authors: Hajam IA, Tsai CM, Gonzalez C, Caldera JR, Lázaro Díez M, Du X, Aralar A, Lin B, Duong W, Liu GY

Citation: Nat Commun. 2024 Dec 16;15(1):10335. doi: 10.1038/s41467-024-54644-w.

Specialties: Infectious disease, Immunology

Related content

Publication
IL-1 Receptor 1 Signaling Shapes the Development of Viral Antigen-Specific CD4+ T Cell Responses Following COVID-19 mRNA Vaccination
Publication
A reverse vaccinology approach on transmembrane carbonic anhydrases from Plasmodium species as vaccine candidates for malaria prevention
Conference Presentation
Determining the Immune Landscape of Patients with B- and T-cell Malignancies Utilizing Whole Transcriptome RNA Sequencing and TRUST4

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.